Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript

AMERICAN PHYSICIANS SERVICE GROUP INC (AMPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/29/2021 GN Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 6th, 2021
04/06/2021 GN Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
03/29/2021 GN Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection
03/15/2021 GN Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
03/08/2021 GN Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
02/26/2021 GN Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
12/29/2020 GN Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
11/06/2020 GN Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
10/06/2020 GN Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection
09/03/2020 GN Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
07/30/2020 GN Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
06/19/2020 GN Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
06/12/2020 GN Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
06/09/2020 GN Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
06/02/2020 GN Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
05/07/2020 GN Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
04/27/2020 GN Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
04/13/2020 GN Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
04/09/2020 GN Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
03/05/2020 GN Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020
01/28/2020 GN Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
11/27/2019 GN Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference
11/15/2019 GN Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/01/2019 GN Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019
08/29/2019 GN Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference
06/24/2019 GN Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
06/19/2019 GN Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
06/14/2019 GN Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
05/31/2019 GN Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
05/10/2019 GN Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
05/06/2019 GN Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019
03/19/2019 GN Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial
02/26/2019 GN Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental — Emerging Consolidated Expectations, Analyst Ratings
01/03/2019 GN Amphastar Pharmaceuticals, Inc. Announces Launch of Primatene® MIST to Nationwide Retail Pharmacies
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy